Evidence map›Paper›PMID 34298839›Full record

ArticleCancers2021

Prognostic Impact of Immunoglobulin Kappa C (

Marcus Schmidt, Karolina Edlund, Jan G Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Antje Lebrecht, Slavomir Krajnak, Marco J Battista, Walburgis Brenner, Annette Hasenburg and 5 more

Open access · greenAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Marcus SchmidtDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0003-1365-2414
Karolina EdlundLeibniz Research Centre for Working Environment and Human Factors (IfADo) at Dortmund TU, 44139 Dortmund, Germany.ORCID 0000-0002-0276-2143
Jan G HengstlerLeibniz Research Centre for Working Environment and Human Factors (IfADo) at Dortmund TU, 44139 Dortmund, Germany.
Anne-Sophie HeimesDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Katrin AlmstedtDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Antje LebrechtDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Slavomir KrajnakDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Marco J BattistaDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Walburgis BrennerDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-1511-6212
Annette HasenburgDepartment of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany.
Jörg RahnenführerDepartment of Statistics, TU Dortmund University, 44221 Dortmund, Germany.
Mathias GehrmannBayer AG, 42113 Wuppertal, Germany.
Pirkko-Liisa Kellokumpu-LehtinenCancer Centre, Tampere University Hospital and University of Tampere, 33520 Tampere, Finland.
Ralph M WirtzSTRATIFYER, 50935 Köln, Germany.
Heikki JoensuuDepartment of Oncology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.
Johannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DETU Dortmund University · DEBayer (Germany) · DEHelsinki University Hospital · FILeibniz Research Centre for Working Environment and Human Factors · DETampere University · FI

Funding

Bundesministerium für Bildung, Wissenschaft und Forschung 01GR0816
6 · The paper itself

Abstract

We studied the prognostic impact of tumor immunoglobulin kappa C (

Indexed as

immune systemimmunoglobulin kappa Cprognosistriple-negative breast cancer

Identifiers

PMID34298839
PMCPMC8304855
OpenAlexW3184170858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.